Colorectal Cancer Clinical Trials in Long Beach, CA

Colorectal Cancer Clinical Trials in Long Beach, CA

View the best 10 colorectal cancer medical studies in Long Beach, California. Access promising new therapies by applying to a Long Beach-based Colorectal Cancer clinical trial.

Trials in Long Beach, California

Here are the top 10 medical studies for colorectal cancer in Long Beach, California

Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

mFOLFIRINOX

Recruiting1 awardPhase 2 & 3
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Image of Kaiser Permanente Orange County Anaheim/Irvine Medical Center Oncology Clinics in Anaheim, United States.

Embedded primary care in cancer survivorship model

Behavioural Intervention

Recruiting1 award7 criteria
This trial looks at two different ways of providing care to cancer survivors to see which is more effective.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Leucovorin Calcium, Fluorouracil, Oxaliplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.
Image of Cancer Specialists of North Florida in Jacksonville, United States.

Sotorasib +1 More

Targeted Therapy

Recruiting2 awardsPhase 3
"This trial aims to see if a new treatment called sotorasib, along with panitumumab and FOLFIRI, can improve the time before the cancer progresses in patients with metast
Image of Yale University Cancer Center in New Haven, United States.

GEN1042

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called GEN1042 to see if it can help treat advanced cancer. It focuses on patients whose cancer has spread or is hard to treat. The goal is to find out if GEN1042 can safely reduce or stop tumor growth.
Image of St. Bernards Medical Center in Jonesboro, United States.

Onvansertib

Protein Kinase Inhibitor

Recruiting1 awardPhase 2
This trial aims to determine the most effective dose of onvansertib and evaluate its safety and effectiveness when combined with certain chemotherapy regimens in patients with a specific type of colorectal cancer that has
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Irinotecan +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing if vitamin D3 along with regular cancer drugs and another drug that helps the immune system can better treat colorectal cancer that has spread. Vitamin D3 may help the body use essential minerals, making the cancer drugs more effective. Vitamin D3 has been shown to slow down cancer cell growth and help them mature, and it has been effective in reducing intestinal tumors in animal studies.
Image of Next Oncology in Fairfax, United States.

CBP-1019

Bi-specific Ligand Conjugated Drug

Recruiting1 awardPhase 1 & 2
This trial is testing CBP-1019, a drug that targets cancer cells, in patients with advanced solid tumors who have no other treatment options. The drug works like a guided missile, finding and attacking cancer cells more precisely.
Image of Alaska Oncology in Anchorage, United States.

Capecitabine +3 More

Anti-metabolites

Recruiting1 awardPhase 1 & 2
This trial studies a combo therapy for colorectal cancer, to see if it's safe and effective.
Image of Charles R. Drew University in Los Angeles, United States.

Intervention Group (IG)

Behavioral Intervention

Recruiting1 award8 criteria
This trial observes the impact of a tailored education program on colorectal cancer screening & dietary habits in minority patients w/ type 2 diabetes.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.